Sean McCutcheon
Stock Analyst at Raymond James
(n/a)
# 4,397
Out of 4,762 analysts
5
Total ratings
n/a
Success rate
-34.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENGN enGene Holdings | Initiates: Outperform | $23 | $5.15 | +346.60% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $13.45 | +197.40% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $44.40 | +57.66% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $37.19 | +131.24% | 1 | Mar 13, 2024 |
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $5.15
Upside: +346.60%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $13.45
Upside: +197.40%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $44.40
Upside: +57.66%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $37.19
Upside: +131.24%